Back to search

Article

Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed the testable therapeutic target

2021-09-15

Abstract excerpt

<h4>SUMMARY</h4> Metabolic aberrations impact the pathogenesis of multiple sclerosis (MS) and possibly can provide clues for new treatment strategies. Using untargeted metabolomics, we measured serum metabolites from 35 relapsing-remitting patients and 14 healthy age-matched controls. Out of 632 known metabolites detected, 60 were significantly altered in relapsing-remitting MS (RRMS). Bioinformatics analysis ide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65cce0de-ee2e-5146-8647-5e6cfa7caea2
DOI
10.1101/2021.09.13.460085
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed the testable therapeutic targetDOI 10.1101/2021.09.13.460085
Select a neighboring publication to make it the new centre.